Similarly, a pooled analysis of five prospective cohort studies involving 470 pancreatic cancer cases found no evidence of an association of IL6, C-reactive protein (CRP) or TNFα receptor 2 with pancreatic cancer risk.40 This evidence concerns the gene CRP and pancreatic neoplasm.